+ Equity
AI-driven genetic analysis platform
Job no longer available
AI-driven genetic analysis platform
21-100 employees
Job no longer available
+ Equity
21-100 employees
To help people with genetic diseases to start a new journey.
Share this job
Feb 2022
$5.7m
SEED
About 475 million people, or 10 percent of the world's population, suffer from rare diseases, and over 80% of them are genetic in nature. Nostos Genomics is an AI-driven genetic analysis platform that enables genetic testing labs to give more people a clear and fast diagnosis.
The platform’s AI solution “AION” automatically identifies pathogenic variants and genetic mutations through leveraging a combination of machine learning and functional genomics. Typically, the average diagnosis time for these tests is 4-5 years, but sometimes patients can be looking at closer to a decade. This lead time paired with extensive and expensive workups and testing is telling of how transformative Nostos Genomics technology can be.
The company recently received a new influx of funding which it hopes to put towards quickly expanding the team, entering a series of new markets including the US, and conducting more studies to further develop its platform.
Kirsty
Company Specialist at Welcome to the Jungle